Facebook Linkedin Twitter
Inside Precision Medicine Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders

Triple-negative breast cancer

Translucent image of a woman's torso showing triple negative breast cancer in one breast
Molecular Dx

Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders

Helen Albert -
0
IPM February 2024 issue Liebman graphic
Informatics

AI, Dogma, and Drug Development

Kathy Vuksanaj -
0
Triple negative breast cancer cell undergoing retraction and apoptosis
News & Features

Atezolizumab Add-on Boosts Carboplatin Chemotherapy in Metastatic TNBC

Chris Anderson -
0
Woman cancer patient
News & Features

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset

Malorye Branca -
0
Breast cancer. TNBC
News & Features

Inhibiting Two Proteins Could Be an Effective Treatment for Triple-Negative Breast Cancer

Uduak Thomas -
0
Triple negative breast cancer cell undergoing retraction and apoptosis
News & Features

Drug Targeting Protein May Be Key to Treating Triple-Negative Breast Cancer

Christina Jackson -
0
cancer cells, illustration
News & Features

Neoadjuvant Checkpoint Inhibitor Use Has Untapped Research Benefits Says New Review

Malorye Branca -
0
Dividing breast cancer cell
News & Features

Druggable Target Discovered in Immunotherapy-Resistant Triple-Negative Breast Cancer

Chris Anderson -
0
Conceptual image for viral ethiology of prostate cancer
News & Features

Metabolic Biomarkers Linked to Metastatic Prostate Cancer in Black Men

Chris Anderson -
0
Genetic research, liquid biopsy conceptual illustration
Molecular Dx

Medicare Green Lights Coverage of Signatera MRD Test for Breast Cancer

Chris Anderson -
0
1234Page 1 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine